KAYLEE BEALS: Open Payments
NPI 1093429300 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 57 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,878 · 2025 $1,206
Food & beverage: $1,176Education: $31
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $181 |
| GlaxoSmithKline, LLC. | 9 | $136 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Gilead Sciences, Inc. | 1 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| PFIZER INC. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Iovance Biotherapeutics, Inc. | 2 | $42 |
Products named: KEYTRUDA, Trodelvy, OPDIVO, IBRANCE, JEMPERLI, Fabhalta, OJJAARA, PLUVICTO.
Industry payments across IL — which companies pay providers there.
